image
Healthcare - Medical - Healthcare Information Services - NYSE - US
$ 215.78
-2.72 %
$ 35.1 B
Market Cap
48.63
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one VEEV stock under the worst case scenario is HIDDEN Compared to the current market price of 216 USD, Veeva Systems Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one VEEV stock under the base case scenario is HIDDEN Compared to the current market price of 216 USD, Veeva Systems Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one VEEV stock under the best case scenario is HIDDEN Compared to the current market price of 216 USD, Veeva Systems Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart VEEV

image
$255.0$255.0$250.0$250.0$245.0$245.0$240.0$240.0$235.0$235.0$230.0$230.0$225.0$225.0$220.0$220.0$215.0$215.0$210.0$210.0$205.0$205.0Nov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 Apr
FINANCIALS
2.75 B REVENUE
16.20%
691 M OPERATING INCOME
61.05%
714 M NET INCOME
35.84%
1.09 B OPERATING CASH FLOW
19.61%
-700 M INVESTING CASH FLOW
34.95%
26.1 M FINANCING CASH FLOW
261.32%
721 M REVENUE
3.10%
188 M OPERATING INCOME
3.90%
196 M NET INCOME
0.00%
69.5 M OPERATING CASH FLOW
-57.63%
-15.7 M INVESTING CASH FLOW
94.74%
20.8 M FINANCING CASH FLOW
60.58%
Balance Sheet Veeva Systems Inc.
image
Current Assets 6.31 B
Cash & Short-Term Investments 5.15 B
Receivables 1.06 B
Other Current Assets 101 M
Non-Current Assets 1.03 B
Long-Term Investments 0
PP&E 120 M
Other Non-Current Assets 911 M
70.17 %14.40 %12.41 %Total Assets$7.3b
Current Liabilities 1.4 B
Accounts Payable 30.4 M
Short-Term Debt 9.97 M
Other Current Liabilities 1.36 B
Non-Current Liabilities 109 M
Long-Term Debt 65.8 M
Other Non-Current Liabilities 43.2 M
90.09 %4.37 %2.86 %Total Liabilities$1.5b
EFFICIENCY
Earnings Waterfall Veeva Systems Inc.
image
Revenue 2.75 B
Cost Of Revenue 700 M
Gross Profit 2.05 B
Operating Expenses 1.36 B
Operating Income 691 M
Other Expenses -22.7 M
Net Income 714 M
3b3b3b3b2b2b2b2b1b1b500m500m003b(700m)2b(1b)691m23m714mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
74.53% GROSS MARGIN
74.53%
25.17% OPERATING MARGIN
25.17%
26.00% NET MARGIN
26.00%
12.24% ROE
12.24%
9.73% ROA
9.73%
9.02% ROIC
9.02%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Veeva Systems Inc.
image
1b1b1b1b800m800m600m600m400m400m200m200m00201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 714 M
Depreciation & Amortization 39.4 M
Capital Expenditures 0
Stock-Based Compensation 437 M
Change in Working Capital 7.62 M
Others 11.5 M
Free Cash Flow 1.09 B
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Veeva Systems Inc.
image
Wall Street analysts predict an average 1-year price target for VEEV of $238 , with forecasts ranging from a low of $197 to a high of $285 .
VEEV Lowest Price Target Wall Street Target
197 USD -8.70%
VEEV Average Price Target Wall Street Target
238 USD 10.14%
VEEV Highest Price Target Wall Street Target
285 USD 32.08%
Price
Max Price Target
Min Price Target
Average Price Target
300300280280260260240240220220200200180180160160Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 10
6. Ownership
Insider Ownership Veeva Systems Inc.
image
Sold
0-3 MONTHS
1.28 M USD 3
3-6 MONTHS
660 K USD 2
6-9 MONTHS
471 K USD 1
9-12 MONTHS
2.76 M USD 1
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
3 Medical Info Systems Stocks to Ride the AI Wave in Trump Tariff Era Zacks Medical Info Systems industry stocks like VEEV, HIMS and BFLY are expected to gain from the Stargate Project and provide relief amid tariff tension. zacks.com - 1 week ago
Wall Street Bulls Look Optimistic About Veeva (VEEV): Should You Buy? The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. zacks.com - 2 weeks ago
Don't Try to Time the Market: These 2 Stocks Are Buys Regardless of What Happens Next Equity markets have been seesawing for the past two weeks. Stocks fell hard after President Donald Trump announced his tariff plans, then bounced back big once he said he would pause expanded tariffs on imported goods from most countries for 90 days. fool.com - 2 weeks ago
Here is What to Know Beyond Why Veeva Systems Inc. (VEEV) is a Trending Stock Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock. zacks.com - 2 weeks ago
Flatiron Health Joins Veeva's Product Partner Program to Accelerate Oncology Clinical Research NEW YORK--(BUSINESS WIRE)--Flatiron Health, a healthtech company transforming clinical research through solutions that integrate research into everyday care, today announced they will partner with Veeva Systems, a global leader in cloud software for the life sciences industry. As part of the partnership, Flatiron Health will join the Veeva Product Partner Program. This collaboration builds on the integration of Flatiron Clinical Pipe™ and Veeva EDC (Electronic Data Capture), enhancing value and. businesswire.com - 2 weeks ago
Veeva Systems (VEEV) Registers a Bigger Fall Than the Market: Important Facts to Note Veeva Systems (VEEV) closed the most recent trading day at $222.72, moving -0.42% from the previous trading session. zacks.com - 2 weeks ago
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now. zacks.com - 3 weeks ago
Veeva (VEEV) Moves 3.7% Higher: Will This Strength Last? Veeva (VEEV) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term. zacks.com - 3 weeks ago
2 Top Growth Stocks to Buy and Hold for the Next 20 Years One of the keys to successful investing is holding shares of companies that can perform well over long periods. However, few companies can thrive for that long while delivering excellent returns to investors. fool.com - 3 weeks ago
Why Is Veeva (VEEV) Down 6.2% Since Last Earnings Report? Veeva (VEEV) reported earnings 30 days ago. What's next for the stock? zacks.com - 4 weeks ago
Why a Clutch of Pharmaceutical and Biotech Stocks Escaped the Market's Swoon on Thursday As predicted by many analysts, economists, and investors, the sweeping tariffs announced by the Trump administration on Wednesday decimated the stock market on Thursday. It had one of its worst trading days in years, and almost no sector of the economy was spared. fool.com - 4 weeks ago
New Strong Buy Stocks for April 3rd NATL, BGC, NPSNY, ALX and VEEV have been added to the Zacks Rank #1 (Strong Buy) List on April 3, 2025. zacks.com - 4 weeks ago
8. Profile Summary

Veeva Systems Inc. VEEV

image
COUNTRY US
INDUSTRY Medical - Healthcare Information Services
MARKET CAP $ 35.1 B
Dividend Yield 0.00%
Description Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of software, data, and analytics solutions, which include Veeva customer relationship management (CRM) and Veeva Medical CRM, Veeva CLM, Veeva CRM MyInsights, Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage, Veeva Align, Veeva CRM Events Management, Veeva Nitro, Veeva OpenData, Veeva Link, Veeva Network, Veeva Crossix, Veeva Data Cloud, and MyVeeva for Patients; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including sales and marketing, and medical content and communications, as well as research and development functions, such as clinical, regulatory, quality, and safety. It also provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
Contact 4280 Hacienda Drive, Pleasanton, CA, 94588 https://www.veeva.com
IPO Date Oct. 16, 2013
Employees 7291
Officers Mr. Jacques Mourrain Ph.D. Vice President of Quality, Regulatory & Compliance Mr. Gunnar Georg Hansen Director of Investor Relations Ms. Eleni Nitsa Zuppas President & Chief of Staff Mr. Pinal Patel Chief Information Officer Mr. Brian Van Wagener Chief Financial Officer Ms. Vivian Welsh Chief People Officer Mr. Thomas D. Schwenger President & Chief Customer Officer Ms. Kristine B. Diamond Principal Accounting Officer Mr. Jonathan W. Faddis J.D. Senior Vice President, General Counsel & Corporate Secretary Mr. Peter P. Gassner Founder, Chief Executive Officer & Director